| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.081 | 0.5 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |